A Study of Divalproex Sodium in Children With Autism Spectrum Disorder and Epileptiform EEG.

Trial Profile

A Study of Divalproex Sodium in Children With Autism Spectrum Disorder and Epileptiform EEG.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 02 Feb 2017

At a glance

  • Drugs Valproate semisodium (Primary)
  • Indications Asperger syndrome; Autistic disorder; Pervasive child development disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Dec 2011 Status changed from completed to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 31 Jan 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 31 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top